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Abstract
Deficiency of 21 hydroxylase enzyme deficiency
(21OH) activity accounts for 90% cases of congenital
adrenal hyperplasia (CAH). This results in deficient
cortisol, increased ACTH, adrenal hyperplasia and
increased adrenal androgen secretion. There is marked
virilization in genetic females which is the hallmark of this
disorder. Genetic heterogeneity in 21 OHD is well
recognized, and both severe and mild forms occur. We
present three cases of adult females with the disease from a
larger study to establish genotype, phenotype correlation of
Pakistani patients with congenital adrenal hyperplasia
(CAH) and to highlight issues such as diagnostic delay,
inappropriate gender assignment at birth, and high degree of
consanguinity among parents, psychosexual outcome of 21
OHD females and the need to develop expertise for early
case detection. The analysis was done using Amplification
Refractory Mutation System (ARMS) PCR. These cases
show that CAH frequently remains undiagnosed during the
newborn period in our population due to lack of awareness
in the society and lack of proper diagnosis by the primary
physician. There is a need to develop expertise for early
case detection.
Introduction
Congenital adrenal hyperplasia (CAH) is an inborn
error of metabolism in steroid hormone synthesis in the
adrenal cortex. It is also the most common cause of
ambiguous genitalia in newborn. In 90-95% of the cases, it
occurs due to deficiency of Steroid 21-hydroxylase enzyme
(21OH). This deficiency results in decreased synthesis of
cortisol and aldosterone and overproduction of adrenal
androgens.1
Depending upon the degree of enzyme deficiency
the synthesis of aldosterone and androgens is affected in
different ways thus producing a wide range of presentations.
In its severe form the newborn males and females present
with salt wasting crises (SW-CAH) or females present with
features of prenatal virilization (SV-CAH), often giving
uncertainty in sex assignment and requiring cumbersome
genital surgery. Mild forms, also known as late onset, non-
classical (NC-CAH) can present with menstrual
disturbances, infertility, hirsutism in adult females;
infertility and acne in adult males.1,2
Clinical variation is due to different mutations in
the gene, CYP21 encoding the enzyme 21 OH. Specific
mutations produce a given degree of enzymatic
compromise and give rise to various clinical forms of
21OH deficiency. Patients deficient in 21OH activity are
divided according to their predicted enzyme activity in
relation to the genotype found into; null, A, B and C
mutations. In Null group, there is complete enzyme
inactivation and patients manifest with severe salt wasting.
Mutations in type A produces low but measurable enzyme
activity and patients can present with neonatal virilization
both with and without SW. Type B mutations are less
severe and are associated with neonatal virilization
without salt wasting. Group C mutations are associated
with late onset disease. Therefore, genotyping is used to
predict the clinical outcome in patients with 21-OHD and
is a useful way to grade the severity of the disease and
predict the therapeutic interventions with cortisol and
aldosterone.2,3 Prenatal diagnosis can be made so that
affected females are treated in utero, to reduce the
virilizing genital malformation while the treatment of
unaffected can be avoided.4,5
Previously we reported paediatric cases of
congenital adrenal hyperplasia due to 21OH deficiency
from our hospital. Some of the key features identified
included diagnostic delay, inappropriate gender assignment
at birth, increased number of infant deaths, and high rate of
consanguinity.6,7 We present three cases of adult females
with the disease from a larger study to establish genotype:
phenotype correlation of congenital adrenal hyperplasia
(CAH) patients to highlight issues and emphasize the role of
genotyping for evaluation of such cases.
Case-1:
An unmarried female presented to us at 47 years of
age with ambiguous genitalia since birth. However, no
medical consultation was sought and she was raised as a
female. She belonged to a well to-do Punjabi family and a
product of consanguineous marriage. At puberty, she
developed hoarseness of voice and never developed
menarche until the age of 47 when she had bleeding per
vaginum and was taken for medical consultation and
investigated for congenital adrenal hyperplasia (CAH).
Clinical examination revealed pigmentation of the skin
and hirsutism, male distribution of body hair and breast
were in prader score Bo. Examination of genitalia showed
clitoral enlargement, ventral binding, scrotalization of the
skin, presence of urogenital sinus, fusion of the
labioscrotal folds, clitoral index was above 3.5 cm.
Investigations performed revealed high 17 OH
Progesterone  (60.8 ng/ml; reference range: 0.22 to 4.69
ng/ml) and testosterone (741 ng/dl; reference range: 6 to
82 ng/dl ). Karyotyping was XX. She never had a salt-
wasting crisis and therefore was diagnosed as simple
virilizing congenital adrenal hyperplasia.
Case-2:
The other married Pathan woman from Peshawar
residing in Karachi presented at the age of 24 years. Her
symptoms started at the age of 16 years when she developed
hoarseness of voice and hirsutism. Her menarche was
delayed. Initially she had menstrual irregularities with
scanty flow but later the cycles became regular. She was
married at 17 years of age. She remained infertile and her
husband had a second marriage after some years, as he
wanted to have children. His second wife was pregnant and
this lady came to the clinic for treatment. On examination,
she had male distribution of body hair with temporal
recession. There was no breast development (prader stage
Bo). Her genitalia were unambiguously female with
posterior labial fusion and with a clitoral index of 3.5 cm.
Her 17 OH Progesterone levels were raised at 185 ng/ml.
Ultrasound showed normal internal female genitalia. She
was started with 7.5 mg of prednisolone daily Follow-up
after 3 months showed breast development (prader stage
B2). A decrease in the hair growth was also observed. She
also started having normal menstrual cycles and became
pregnant.
Case-3:
An unmarried female of Indian origin presented at
20 years of age with primary amenorrhea and hirsutism. Her
parents were first cousins. On examination her breasts were
not developed (Bo), there was clitoromegaly (CI 92 mm)
and posterior labial fusion. She was diagnosed to have Non
classical form of congenital adrenal hyperplasia (NC-CAH)
with a 17-hydroxyprogesterone (17 OHP) level of 720
ng/ml. She started menstruating after initiation of therapy.
She took deltacortil for 8 years and then left the treatment
on her own and was lost to follow-up. At 30 years of age she
once again presented with extreme stress due to her disease.
She was advised to start the treatment and counseled about
the disease prospects. 
Molecular Analysis:
Genomic DNA was extracted from leukocytes
using genomic DNA purification kit (Promega, USA).
Purified DNA was screened for mutations in CYP21 gene
using allele specific Polymerase Chain Reaction. In the
initial round of amplification, two overlapping fragments;
labeled A&B of CYP21 gene were amplified using high
fidelity PCR master mix kit according to manufacturer'
instructions (Roche Diagnostic, Mannheim Germany).
Briefly, 250ng of genomic DNA in 50 µl volume along
with 30 ng of specific primers P1 and P48 for fragment A,
primers P4 and P55 were used for fragment B in PCR
mixture containing high fidelity master was recycled at
94ºC for 30 seconds, 56ºC for 30 seconds and 72ºC for 1
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minute for 35 cycles with 5 second increments in each
cycle. Amplified fragments were separated on 1% agarose
gel and submitted to second round of PCR to detect
mutation Pro31leu at nucleotide position 92 and interon2
splice at nucleotide position 659 in fragment A.
Ile173Asn, Arg357Trp, Gln319stop, Leu308insT,
Val282Leu, Val238Glu, nucleotide position 1004, 2113,
1999, 1768, 1688, and 1388 in fragment B respectively.
Amplified products were separated on 3% agarose gel
stained with ethidium bromide and visualized under Ultra-
Violet light for photography.
Results
Figure-1 shows results of the molecular analysis.
Mutations Ile173Asn causing a substitution of A for T at
nucleotide position 1004 in case 1 and 3. These
mutations are associated with Simple virilization form
of congenital adrenal hyperplasia (SV-CAH). PCR
failure was noted in case 2, which may be due to new
mutations. For such samples DNA sequencing is
required for verification.
Discussion
Two patients had Ile173Asn mutation which causes
protein change from ATC>AAC at nucleotide position 1004
in Exon 4. Ile173Asn mutation is classified as type B since
it is considered slightly less severe and is usually associated
with neonatal virilization without salt wasting and was also
identified in salt wasting congenital adrenal hyperplasia
(SW-CAH) patients. The mutation reduced enzyme activity
to 10% in vitro. Case 2 may have new mutation and in this
case direct sequencing is valuable as a complement to
mutation screening for the characterization of the novel
mutation and additional rare mutations. 
In our patients, the results of genotyping showed
Simple virilization form of CAH (SV-CAH) without SW.
However, symptoms of androgen excess were not noted at
birth or in early childhood and, due to late presentation,
cases 2 and 3 were labeled as Non-classical congenital
adrenal hyperplasia (NC-CAH). Non-classical congenital
adrenal hyperplasia of 21 OHD presents in later
childhood, at puberty or in adult life with signs of
androgen excess and hence its name as late onset or
acquired form of congenital adrenal hyperplasia (CAH).
In case 1, despite having virilizing features; medical
consultation was not sought.
Early diagnosis in congenital adrenal hyperplasia
(CAH) is essential to avoid adrenal crises and to ensure
normal physical, psychosocial development and fertility.8,9
Frequent diagnostic delay has been reported in literature,
however after 1970, the diagnostic rate improved in many
countries due to better diagnostic tests and improvement in
clinical awareness of this disorder. Later in some countries
screening for congenital adrenal hyperplasia was also
introduced. Our data shows that congenital adrenal
hyperplasia frequently remains undiagnosed during the
newborn period in our population primarily due to lack of
awareness, non availability of proper diagnosis, false social
beliefs, and religious dogmas. In Pakistan, there is ethnic
diversity; the prevalence of congenital adrenal hyperplasia
may vary in different ethnic groups. Our three cases are
from three different ethnic backgrounds. This shows that
congenital adrenal hyperplasia (CAH) cases are prevalent in
people from different ethnic backgrounds in Pakistan.
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Figure1: Detection of Ile173Asn mutation at nucleotide position 1004 by ARMS PCR.
Figure shows  detection of Ile173Asn Mutation for case 1 and 2 at  nucleotide position1004 by ARMS PCR lane1 shows amplification of
fragment B at  position 1004 case 2. MM = Molecular marker FX174 (72-1353 bp).
Reproductive abnormalities such as increased risk
of developing polycystic ovarian syndrome;
developmental anomalies like labial fusion may leave the
vaginal introitus inadequate for successful intercourse,
are seen in our cases and have been reported in literature.
An enlarged clitoris also, often requires surgical
correction. Surgical correction may be necessary
depending on the degree of virilization. Issues of female
fertility and optimal management for pregnant females
are equally important.9-11 Many women in our set-up do
not routinely see a gynecologist at any stage as an adult,
despite having undergone reconstructive surgery of
clitoris and vagina as a child. It is important to maintain
glucocorticoids replacement at pre pregnancy doses, and
to monitor testosterone and 17α-hydroxyprogesterone.
Early exposure of brain to hyperandrogenism is
responsible for many of the psychological outcomes
noted. Social and emotional well being is also lower than
the general population.
Conclusion
Congenital adrenal hyperplasia (CAH)
frequently remains undiagnosed during the newborn
period in our population due to lack of awareness in the
society and lack of proper diagnosis by the primary
physician. There is a need to develop expertise for early
case detection. Being an autosomal recessive disease,
children are born to parents unaware of the risk and
with no family history. To minimize the degree of
virilization in females, prenatal diagnosis should be
available to high risk families so that the treatment can
be started in genetically affected females during the
antenatal period.
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